Hexiscrub4%

Hexiscrub is a topical antiseptic/antimicrobial skin cleanser. Evidence for its use comes from FDA OTC antiseptic monograph data and long-standing clinical practice; it is not intended for systemic or internal use. Classified uses include:

• Established/approved uses: Surgical hand and forearm scrub for surgical personnel before operative procedures; healthcare personnel handwash to reduce transient and resident skin flora; patient preoperative skin preparation before surgery or invasive procedures.
• Established/approved use: General antiseptic skin cleansing (e.g., before injections, venipuncture) to help reduce bacteria on the skin.
• Guideline-supported use: Whole-body antiseptic bathing/showering the night before and/or morning of surgery as part of surgical site infection (SSI) prevention protocols in some hospital settings.

Hexiscrub is intended for external topical use on intact skin only; it is not indicated for treating an existing infection, wound irrigation beyond labeled use, mucous membrane application, or oral/internal use.

Each 100 mL of the topical solution/scrub typically contains Chlorhexidine Gluconate [4%] equivalent to 4 g chlorhexidine gluconate (4% w/v) in an aqueous, detergent (surfactant) base suitable for skin cleansing. Marketed presentations (bottles, foam pumps, single-use sponges/applicators) and exact excipients may vary by manufacturer; check the product label for the formulation dispensed.

Hexiscrub is a broad-spectrum topical antiseptic belonging to the bisbiguanide chemical class. At the 4% concentration, it is formulated as a surgical scrub and skin cleanser combining chlorhexidine's antimicrobial activity with a mild detergent base, producing both immediate microbial reduction and a persistent (residual) antimicrobial effect on the skin after rinsing. It is available as a liquid solution, foaming cleanser, or impregnated sponge/applicator for external use only.

Topical antiseptic / antimicrobial skin cleanser (bisbiguanide class) — Hexiscrub

Mechanism of Action

Chlorhexidine Gluconate [4%] is a cationic bisbiguanide that binds to and disrupts the negatively charged cell membranes of bacteria, fungi, and some enveloped viruses. At lower concentrations it is bacteriostatic (increasing membrane permeability and leakage of cell contents); at the higher 4% concentration used here, it is bactericidal, causing precipitation and coagulation of cytoplasmic contents and cell death. It has broad-spectrum activity against many gram-positive and gram-negative bacteria, and some activity against fungi and lipid-enveloped viruses; activity against bacterial spores and non-enveloped viruses is limited.

Pharmacokinetics

Chlorhexidine Gluconate [4%] is intended for external use only. Systemic absorption through intact skin is minimal to negligible under normal use conditions. A distinguishing pharmacologic feature is substantivity — it binds to skin proteins (stratum corneum) and provides a persistent antimicrobial effect for several hours after a single application, unlike alcohol-based antiseptics that act only transiently.

Apply Hexiscrub to external skin only, using a wet brush, sponge, applicator, or clean hands as appropriate for the specific use. Work into a lather where a detergent base is present, maintain the recommended contact time, then rinse thoroughly with water (or allow to air-dry, if directed, for preoperative skin preparation) before proceeding with the procedure. Avoid contact with eyes, ears, mouth, and mucous membranes during application.

Because Hexiscrub is applied topically with minimal systemic absorption, clinically significant systemic drug interactions are not expected. Well-recognized topical/product-level interactions include:

• Anionic surfactants and soaps: Concomitant or sequential use of Hexiscrub with conventional soaps or other anionic-surfactant-containing products can chemically neutralize chlorhexidine's antimicrobial activity; skin should be adequately rinsed of soap before applying Hexiscrub.
• Other topical antiseptics (e.g., iodine-based products): Mixing or layering Hexiscrub with povidone-iodine or other antiseptics is not recommended, as this may reduce efficacy of one or both agents and increase the risk of skin irritation.

There is no established need to adjust systemic medications because of topical Hexiscrub use.

Most reactions to Hexiscrub are local and related to its antiseptic/detergent action on the skin. Reported effects include:

• Common: Local skin irritation, dryness, mild redness, or a stinging/burning sensation at the application site.
• Less common: Contact dermatitis; photosensitivity has rarely been reported.
• Rare but serious: Hypersensitivity reactions ranging from rash and urticaria to, rarely, severe anaphylactic reactions (see Contraindications). Ototoxicity if the product enters the middle ear, or corneal/eye injury if it contacts the eyes (see Contraindications and Precautions).

Discontinue use and seek medical attention if signs of an allergic reaction (rash, hives, difficulty breathing, facial or throat swelling) occur.

Hexiscrub is applied topically to intact skin with minimal systemic absorption, and significant fetal or infant exposure is not expected with labeled use. However, well-controlled studies in pregnant or breastfeeding women are lacking. As a general precaution, Hexiscrub should be used during pregnancy and lactation only if clearly needed, avoiding application to large skin areas, broken skin, or mucous membranes, and potential benefit should justify any theoretical risk; consult a physician before use in these situations.

Hexiscrub is for external topical use only and is not intended for ophthalmic, otic (middle ear), oral, or general mucous membrane use. Additional precautions include:

• Use only as an external antiseptic; avoid routine application to broken skin, open wounds, or mucous membranes beyond labeled indications, as this may increase irritation or absorption risk.
• When used before procedures involving electrocautery or other ignition sources, allow treated skin to dry completely before draping; alcohol-containing Hexiscrub preparations are flammable and pose a fire risk if not fully dried.
• Discontinue use and seek prompt medical attention if signs of an allergic or hypersensitivity reaction (rash, difficulty breathing, swelling) occur.
• Hexiscrub is not intended for oral ingestion and must not be used as a general-purpose skin lotion, moisturizer, or cosmetic cleanser.
• Use exactly as directed on the product label or by your healthcare provider/institutional protocol; do not use more often, in larger amounts, or for longer than directed, and do not share or repurpose this antiseptic product for uses other than intended without medical advice.

Hexiscrub is intended solely for external topical use, and true systemic overdose from correct topical application is not expected. If a large amount is accidentally swallowed, or if it contacts the eyes, ears, or an open wound/mucous membrane in a way that causes injury or irritation, rinse the affected area thoroughly with plenty of clean water and seek immediate medical attention or contact a poison control center/emergency services. Do not attempt to induce vomiting or use unproven home remedies.

Store at room temperature (below 30°C), away from light and moisture. Keep the container tightly closed and out of reach of children.

Neonates and premature infants: Safety and efficacy of Hexiscrub have not been firmly established in this population; use with caution, as neonatal skin is thinner and more susceptible to irritation and chemical injury, and avoid prolonged or occlusive contact.

Renal or hepatic impairment: No dose adjustment is required for topical Hexiscrub, as systemic absorption is minimal.

Elderly: No specific dose adjustment is required; skin may be more fragile, so monitor for irritation.

Patients with known skin sensitivity or eczema: Use with caution and monitor for increased irritation or allergic reactions.

Hexiscrub is typically used as a single application per procedure (e.g., one surgical scrub session, one preoperative skin preparation) or as directed for routine healthcare personnel handwashing/showering protocols. It is not intended for continuous, prolonged, or indefinite use on the same skin area outside of labeled antiseptic/handwashing indications; follow the specific procedure or institutional protocol for frequency and duration.

Topical antiseptic; bisbiguanide antimicrobial agent

Chlorhexidine Gluconate [4%] is a cationic bisbiguanide antiseptic. Its positively charged molecule is attracted to and binds negatively charged sites on microbial cell walls and membranes, increasing membrane permeability. At the bactericidal 4% concentration, this leads to leakage and precipitation of intracellular components and cell death. Chlorhexidine Gluconate [4%] also binds to skin keratin, giving it a persistent (substantive) antimicrobial effect that continues to suppress bacterial regrowth on the skin for several hours after application.

Safety and efficacy of Hexiscrub have not been formally established in neonates and infants under 2 months of age; use in this age group should be limited and cautious due to the risk of skin irritation or chemical burns on immature skin. In older infants, children, and adolescents, Hexiscrub may be used topically for the approved antiseptic indications (e.g., preoperative skin preparation, healthcare handwashing) following the same precautions as in adults, avoiding contact with eyes, ears, and mucous membranes, and under guidance from a healthcare provider.